Literature DB >> 12885232

Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states.

Susanna Hakansson1, Michael Caffrey.   

Abstract

An 11-residue basic domain of the HIV-1 tat protein, termed the tat transduction domain (TTD), has been shown to mediate transfer of biomolecules across biological membranes. The mechanism of TTD-mediated membrane translocation is currently unknown but thought to involve binding to heparan sulfate, which is found in proteoglycans that are ubiquitously present on cell surfaces. To study the mechanism of TTD-mediated membrane translocation, the TTD was fused to the C-terminus of a model cargo protein, the IgG binding domain of streptococcal protein G (PG) to form PG-TTD. NMR studies of PG-TTD in the free state indicated that the structure of the PG moiety of PG-TTD was not perturbed by the presence of the TTD and that the TTD moiety is in an extended conformation. Heteronuclear relaxation measurements of PG-TTD in the free state show that the TTD moiety of PG-TTD is relatively mobile (e.g., the average S(2) value of the TTD and PG core are approximately 0.54 and approximately 0.84, respectively). PG-TTD has been shown to bind to heparin by isothermal titration calorimetry (K(D) = 0.37 microM, Delta H = -12 kcal/mol, Delta S = -11 cal/mol/T). NMR spectroscopy demonstrated that heparin binds to the TTD moiety of PG-TTD. The heteronuclear relaxation measurements of PG-TTD in complex with heparin show that the TTD becomes less dynamic when bound to heparin (average S(2) value of the TTD is 0.69 in the presence of heparin). A model for the first step of TTD-mediated entry into cells is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885232     DOI: 10.1021/bi020715+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

2.  Modeling of the endosomolytic activity of HA2-TAT peptides with red blood cells and ghosts.

Authors:  Ya-Jung Lee; Gregory Johnson; Jean-Philippe Pellois
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

3.  Understanding Cell Penetration of Cyclic Peptides.

Authors:  Patrick G Dougherty; Ashweta Sahni; Dehua Pei
Journal:  Chem Rev       Date:  2019-05-14       Impact factor: 60.622

4.  Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.

Authors:  Gianvito Grasso; Mathieu Heulot; Nadja Chevalier; Evgeniya Trofimenko; Marco A Deriu; Gilles Dubuis; Yoan Arribat; Marc Serulla; Sebastien Michel; Gil Vantomme; Florine Ory; Linh Chi Dam; Julien Puyal; Francesca Amati; Anita Lüthi; Andrea Danani; Christian Widmann
Journal:  Elife       Date:  2021-10-29       Impact factor: 8.140

5.  NMR characterization of the interaction between the C-terminal domain of interferon-gamma and heparin-derived oligosaccharides.

Authors:  Cécile Vanhaverbeke; Jean-Pierre Simorre; Rabia Sadir; Pierre Gans; Hugues Lortat-Jacob
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

6.  A turn-like structure "KKPE" segment mediates the specific binding of viral protein A27 to heparin and heparan sulfate on cell surfaces.

Authors:  Ping-Chen Shih; Min-Shiang Yang; Su-Ching Lin; Yu Ho; Jye-Chian Hsiao; Da-Rong Wang; Steve S-F Yu; Wen Chang; Der-Lii M Tzou
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

7.  Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states.

Authors:  Susanna McReynolds; Shaokai Jiang; Lijun Rong; Michael Caffrey
Journal:  J Magn Reson       Date:  2009-09-19       Impact factor: 2.229

Review 8.  Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges.

Authors:  Alfredo Erazo-Oliveras; Nandhini Muthukrishnan; Ryan Baker; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  Pharmaceuticals (Basel)       Date:  2012-11-01

Review 9.  Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy.

Authors:  Huiyuan Wang; Cheol Moon; Meong Cheol Shin; Yaping Wang; Huining He; Victor C Yang; Yongzhuo Huang
Journal:  Nanotheranostics       Date:  2017-03-03

Review 10.  Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.

Authors:  Karim Shalaby; Mustapha Aouida; Omar El-Agnaf
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.